Should pharma refocus on customers, not shareholders?
A management guru prescribes "radical" changes for Big Pharma--including abandoning DTC advertising. In his view, the industry can only leap ahead when its leaders unlearn traditional management thinking and focus their organizations on continuously delivering more value to customers sooner. Report
Comments